BridgeBio Oncology Therapeutics Inc. (BBOT) vs Indaptus Therapeutics, Inc. (INDP)
A side-by-side comparison of BridgeBio Oncology Therapeutics Inc. and Indaptus Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBOT
BridgeBio Oncology Therapeutics Inc.
$3.62HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
INDP
Indaptus Therapeutics, Inc.
$2.49HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — BBOT vs INDP
growth of $100 · dividends reinvested · last 3yBBOT -64.7% (-29.3%/yr)INDP -94.7% (-62.5%/yr)BBOT compounded faster over this window
Log scale — wide-divergence pair
BBOT INDP
BBOT vs INDP: by the numbers
- •BBOT is the larger company ($290M vs $282M market cap).
Metrics side by side
Valuation
| Metric | BBOT | INDP |
|---|---|---|
| P/B ratio | 0.90 | 24.79 |
Profitability
| Metric | BBOT | INDP |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -56.36% | -135.62% |
| ROIC | -61.10% | -129.90% |
Growth (annualized)
| Metric | BBOT | INDP |
|---|---|---|
| Total return CAGR (5Y) | N/A | -58.32% |
Go deeper
Dig into the metrics
BridgeBio Oncology Therapeutics ROEIndaptus Therapeutics ROEBridgeBio Oncology Therapeutics operating marginIndaptus Therapeutics operating marginBridgeBio Oncology Therapeutics revenue growthIndaptus Therapeutics revenue growthBridgeBio Oncology Therapeutics free cash flowIndaptus Therapeutics free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.